Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yuequn Song, Lifang Meng, Jian Yu, Zhi Cao, Jizhou Sun & Hongyu Zhao. (2021) TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling. Cancer Management and Research 13, pages 5187-5201.
Read now
Read now
Chi Pu, Yangla Ciren, Yun Liu & Ziwen Long. (2021) TRIM52 knockdown inhibits cell proliferation and induces apoptosis through activation of the STAT3 pathway in ovarian cancer1. All Life 14:1, pages 646-656.
Read now
Read now
Chuanjia Yang, Weixue Xu, Jian Gong, Fang Chai, Dongxu Cui & Zhen Liu. (2020) Six1 Overexpression Promotes Glucose Metabolism and Invasion Through Regulation of GLUT3, MMP2 and Snail in Thyroid Cancer Cells. OncoTargets and Therapy 13, pages 4855-4863.
Read now
Read now
Dae-Young Kim, Sun-Ha Moon, Jang-Ho Han, Mi-Jeong Kim, Seong-Ju Oh, Dinesh Bharti, Sung-Ho Lee, Jong-Kuen Park, Gyu-Jin Rho & Byeong-Gyun Jeon. (2020) Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells. Animal Cells and Systems 24:6, pages 329-340.
Read now
Read now
Paweł Jóźwiak, Anna Krześlak, Marek Wieczorek & Anna Lipińska. (2015) Effect of Glucose on GLUT1-Dependent Intracellular Ascorbate Accumulation and Viability of Thyroid Cancer Cells. Nutrition and Cancer 67:8, pages 1335-1343.
Read now
Read now
Articles from other publishers (54)
Priyanka Gautam, Sameer Gupta & Manisha Sachan. (2023) Genome-wide expression profiling reveals novel biomarkers in epithelial ovarian cancer. Pathology - Research and Practice 251, pages 154840.
Crossref
Crossref
Sai-li Duan, Min Wu, Zhe-Jia Zhang & Shi Chang. (2023) The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer. Journal of Translational Medicine 21:1.
Crossref
Crossref
Ali Norouzi, Mahsa Liaghat, Maryam Bakhtiyari, Seyed Mostafa Noorbakhsh Varnosfaderani, Hamidreza Zalpoor, Mohsen Nabi-Afjadi & Tahereh Molania. (2023) The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC). Oral Oncology 144, pages 106483.
Crossref
Crossref
珍 张. (2023) Research Progress on the Factors Affecting Radiotherapy Sensitivity of Cervical Cancer. Advances in Clinical Medicine 13:02, pages 1933-1939.
Crossref
Crossref
Edanur Topal & Yasemin Şanlı. (2022) F-18 FDG PET/CT Imaging in Ovarian Cancer. Nuclear Medicine Seminars 8:3, pages 174-181.
Crossref
Crossref
Haosheng Zheng, Guojie Long, Yuzhen Zheng, Xingping Yang, Weijie Cai, Shiyun He, Xianyu Qin & Hongying Liao. (2022) Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 14:21, pages 5344.
Crossref
Crossref
Marta Baczewska, Elżbieta Supruniuk, Klaudia Bojczuk, Paweł Guzik, Patrycja Milewska, Katarzyna Konończuk, Jakub Dobroch, Adrian Chabowski & Paweł Knapp. (2022) Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications. International Journal of Molecular Sciences 23:16, pages 8968.
Crossref
Crossref
Lichao Guo, Wen Zhang, Yanqi Xie, Xi Chen, Emma E. Olmstead, Mengqiang Lian, Baochen Zhang, Yekaterina Y. Zaytseva, B. Mark Evers, H. Peter Spielmann, Xifu Liu, David S. Watt & Chunming Liu. (2022) Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. Molecular Cancer Therapeutics 21:5, pages 740-750.
Crossref
Crossref
Carlotta Boscaro, Chiara Baggio, Marcello Carotti, Dorianna Sandonà, Lucia Trevisi, Andrea Cignarella & Chiara Bolego. (2022) Targeting of PFKFB3 with miR‐206 but not mir‐26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation. The FASEB Journal 36:3.
Crossref
Crossref
Leszek Szablewski. (2022) Glucose transporters as markers of diagnosis and prognosis in cancer diseases. Oncology Reviews 16:1.
Crossref
Crossref
Ajay Dixit & Mahendra Singh. 2022. Immuno-Oncology Crosstalk and Metabolism. Immuno-Oncology Crosstalk and Metabolism
1
20
.
Daniela B. Vera, Allison N. Fredes, Maritza P. Garrido & Carmen Romero. (2021) Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer. Life 12:1, pages 8.
Crossref
Crossref
Gang Xu, Shouhua Pan, Zhirong Zhu & Junlong Li. (2021) Overexpression of miR-340 inhibits cell proliferation and induces apoptosis of human bladder cancer via targeting Glut-1. BMC Urology 21:1.
Crossref
Crossref
Miaomiao Ye, Yibin Lin, Shuya Pan, Zhi-wei Wang & Xueqiong Zhu. (2021) Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis. Frontiers in Oncology 11.
Crossref
Crossref
Roberto C. Delgado Bolton, Nicolas Aide, Patrick M. Colletti, Annamaria Ferrero, Diana Paez, Andrea Skanjeti & Francesco Giammarile. (2021) EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). European Journal of Nuclear Medicine and Molecular Imaging 48:10, pages 3286-3302.
Crossref
Crossref
Marta Baczewska, Klaudia Bojczuk, Adrian Kołakowski, Jakub Dobroch, Paweł Guzik & Paweł Knapp. (2021) Obesity and Energy Substrate Transporters in Ovarian Cancer—Review. Molecules 26:6, pages 1659.
Crossref
Crossref
Khalid El Bairi, Ouissam Al Jarroudi & Said Afqir. 2021. Ovarian Cancer Biomarkers. Ovarian Cancer Biomarkers
59
133
.
Serag Eldin I. Elbehairi, Lamia A. Ismail, Mohammad Y. Alfaifi, Reda F.M. Elshaarawy & Hani S. Hafez. (2020) Chitosan nano-vehicles as biocompatible delivering tools for a new Ag(I)curcuminoid-Gboxin analog complex in cancer and inflammation therapy. International Journal of Biological Macromolecules 165, pages 2750-2764.
Crossref
Crossref
Sohyun Park, Tae-Sung Kim, Myong Cheol Lim, Sang-Soo Seo, Sokbom Kang, Seok-ki Kim, Chong Woo Yoo & Sang-Yoon Park. (2020) Glycolytic phenotypes in an evaluation of ovarian carcinoma based on carcinogenesis and BRCA mutation. European Journal of Radiology 133, pages 109391.
Crossref
Crossref
Renata Ramalho, Martin Rao, Chao Zhang, Chiara Agrati, Giuseppe Ippolito, Fu-Sheng Wang, Alimuddin Zumla & Markus Maeurer. (2020) Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Seminars in Immunopathology 42:3, pages 279-313.
Crossref
Crossref
Wookyeom Yang, Ha-Yeon Shin, Hanbyoul Cho, Joon-Yong Chung, Eun-ju Lee, Jae-Hoon Kim & Eun-Suk Kang. (2020) TOM40 Inhibits Ovarian Cancer Cell Growth by Modulating Mitochondrial Function Including Intracellular ATP and ROS Levels. Cancers 12:5, pages 1329.
Crossref
Crossref
Jihye Kim, Joon-Yong Chung, Jae Ryoung Hwang, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi & Stephen M. Hewitt. (2020) Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis. Journal of Clinical Medicine 9:4, pages 1137.
Crossref
Crossref
Jacinta Serpa. 2020. Tumor Microenvironment. Tumor Microenvironment
1
34
.
Kristen N. Ruby, Catherine L. Liu, Zhongze Li, Cameron C. Felty, Wendy A. Wells & Shaofeng Yan. (2019) Diagnostic and prognostic value of glucose transporters in melanocytic lesions. Melanoma Research 29:6, pages 603-611.
Crossref
Crossref
Byoung Hyuck Kim & Ji Hyun Chang. (2019) Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer. Scientific Reports 9:1.
Crossref
Crossref
Tong Sun, Bulin Du, Yao Diao, Xuena Li, Song Chen & Yaming Li. (2019) ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway. BMB Reports 52:7, pages 457-462.
Crossref
Crossref
Hang Yang, Jiang-Tao Zhong, Shui-Hong Zhou & He-Ming Han. (2019) Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget 10:32, pages 3066-3083.
Crossref
Crossref
Min Yu, Shengying Chen, Weifeng Hong, Yujun Gu, Bowen Huang, Ye Lin, Yu Zhou, Haosheng Jin, Yanying Deng, Lei Tu, Baohua Hou & Zhixiang Jian. (2019) Prognostic role of glycolysis for cancer outcome: evidence from 86 studies. Journal of Cancer Research and Clinical Oncology 145:4, pages 967-999.
Crossref
Crossref
Domenico Rubello, Maria Cristina Marzola & Patrick M. Colletti. (2019) The role of 18F-FDG PET/CT imaging in the diagnosis of ovarian cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 38:1, pages 50-51.
Crossref
Crossref
D. Rubello, M.C. Marzola & P.M. Colletti. (2019) Papel de la PET/TC con 18F-FDG en el diagnóstico del cáncer de ovario. Revista Española de Medicina Nuclear e Imagen Molecular 38:1, pages 50-51.
Crossref
Crossref
Nomathamsanqa Resegofetse Maimela, Shasha Liu & Yi Zhang. (2019) Fates of CD8+ T cells in Tumor Microenvironment. Computational and Structural Biotechnology Journal 17, pages 1-13.
Crossref
Crossref
Chrysi Xintaropoulou, Carol Ward, Alan Wise, Suzanna Queckborner, Arran Turnbull, Caroline O. Michie, Alistair R. W. Williams, Tzyvia Rye, Charlie Gourley & Simon P. Langdon. (2018) Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment. BMC Cancer 18:1.
Crossref
Crossref
Vertika Rai, Surajit Bose, Rashmi Mukherjee, Arpita Sarbajna & Chandan Chakraborty. (2018) Evaluation of aberrant metabolism related proteins in oral submucous fibrosis: A pilot study. Journal of Oral Biosciences 60:4, pages 87-91.
Crossref
Crossref
Ha-Yeon Shin, Wookyeom Yang, Eun-ju Lee, Gwan Hee Han, Hanbyoul Cho, Doo Byung Chay & Jae-hoon Kim. (2018) Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression. PLOS ONE 13:10, pages e0205297.
Crossref
Crossref
Domenico Rubello, Maria Cristina Marzola & Patrick M. Colletti. (2018) The Prognostic Value of 18F-FDG PET/CT in Monitoring Chemotherapy in Ovarian Cancer Both at Initial Diagnosis and at Recurrent Disease. Clinical Nuclear Medicine 43:10, pages 735-738.
Crossref
Crossref
Amruta Nayak, Arvinder Kapur, Lisa Barroilhet & Manish Patankar. (2018) Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer. Cancers 10:9, pages 337.
Crossref
Crossref
Maria Cristina Marzola, Sotirios Chondrogiannis & Domenico Rubello. (2018) Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer. PET Clinics 13:2, pages 179-202.
Crossref
Crossref
Zheng-Xiao Zhao, Lin-Wei Lu, Jian Qiu, Qiu-Ping Li, Fei Xu, Bao-Jun Liu, Jing-Cheng Dong & Wei-Yi Gong. (2017) Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis. Oncotarget 9:2, pages 2728-2738.
Crossref
Crossref
Katherine A. Zukotynski & Chun K. Kim. (2017) Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers. PET Clinics 12:4, pages 393-405.
Crossref
Crossref
Min Yu, Han Yongzhi, Shengying Chen, Xiaodan Luo, Ye Lin, Yu Zhou, Haosheng Jin, Baohua Hou, Yanying Deng, Lei Tu & Zhixiang Jian. (2017) The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis. Oncotarget 8:26, pages 43356-43367.
Crossref
Crossref
Roman C. Brands, Olga Köhler, Stephan Rauthe, Stefan Hartmann, Harald Ebhardt, Axel Seher, Christian Linz, Alexander C. Kübler & Urs D.A. Müller-Richter. (2016) The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa. Clinical Oral Investigations 21:5, pages 1631-1637.
Crossref
Crossref
Ji Wang, Chenyang Ye, Cong Chen, Hanchu Xiong, Binbin Xie, Jichun Zhou, Yongxia Chen, Shu Zheng & Linbo Wang. (2017) Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget 8:10, pages 16875-16886.
Crossref
Crossref
Kristin G. Anderson, Ingunn M. Stromnes & Philip D. Greenberg. (2017) Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. Cancer Cell 31:3, pages 311-325.
Crossref
Crossref
Wookyeom Yang, Hanbyoul Cho, Ha-Yeon Shin, Joon-Yong Chung, Eun Suk Kang, Eun-ju Lee & Jae-Hoon Kim. (2016) Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer. Oncotarget 7:31, pages 49481-49497.
Crossref
Crossref
KAI LU, JIAN YANG, DE-CHUN LI, SONG-BING HE, DONG-MING ZHU, LI-FENG ZHANG, XU ZHANG, XIAO-CHEN CHEN, BING ZHANG & JIAN ZHOU. (2016) Expression and clinical significance of glucose transporter-1 in pancreatic cancer. Oncology Letters 12:1, pages 243-249.
Crossref
Crossref
Lijun Tan, Weimin Wang, Gong He, Rork D. Kuick, Gabrielle Gossner, Angela S. Kueck, Heather Wahl, Anthony W. Opipari & J. Rebecca Liu. (2015) Resveratrol inhibits ovarian tumor growth in an in vivo mouse model. Cancer 122:5, pages 722-729.
Crossref
Crossref
Asmaa Gaber Abdou, Marwa Mohammad Serag Eldien & Daliah Elsakka. (2015) GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas. International Journal of Surgical Pathology 23:6, pages 447-453.
Crossref
Crossref
Jacqueline C. Brunetti. (2015) Fludeoxyglucose F 18 PET–Computed Tomography. PET Clinics 10:3, pages 395-409.
Crossref
Crossref
Amanda F. Baker, Scott W. Malm, Ritu Pandey, Cindy Laughren, Haiyan Cui, Denise Roe & Setsuko K. Chambers. (2015) Evaluation of a Hypoxia Regulated Gene Panel in Ovarian Cancer. Cancer Microenvironment 8:1, pages 45-56.
Crossref
Crossref
Xiaozhuo Chen, Yanrong Qian & Shiyong Wu. (2015) The Warburg effect: Evolving interpretations of an established concept. Free Radical Biology and Medicine 79, pages 253-263.
Crossref
Crossref
Paweł J�źwiak, Anna Krześlak, Magdalena Bryś & Anna Lipińska. (2014) Glucose-dependent glucose transporter�1 expression and its impact on viability of thyroid cancer cells. Oncology Reports.
Crossref
Crossref
Kurt S Zaenker. (2014) Sweetness in the enigmatic life of cancer cells. Future Oncology 10:11, pages 1815-1817.
Crossref
Crossref
Hanbyoul Cho, Ha-Yeon Shin, Sunghoon Kim, Jane Seon-Young Kim, Joon-Yong Chung, Eun Joo Chung, Kyung-Hee Chun, Stephen M. Hewitt & Jae-Hoon Kim. (2014) The role of S100A14 in epithelial ovarian tumors. Oncotarget 5:11, pages 3482-3496.
Crossref
Crossref
Yanrong Qian. (2014) Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics. World Journal of Translational Medicine 3:2, pages 37.
Crossref
Crossref